Skip to main content

Neupath Health Inc(NPTH-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.460
Day High0.460
Open:0.460
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

Top Stories: Neupath Health Inc

Select a category then submit the form to load news
NEUPATH HEALTH TO REPORT 2025 RESULTS AND HOST INVESTOR WEBINAR
NEUPATH HEALTH ANNOUNCES EXECUTIVE LEADERSHIP CHANGES AS PART OF PLANNED TRANSITION, PRE-ANNOUNCES STRONG 2025 RESULTS
NEUPATH HEALTH ANNOUNCES RENEWAL OF NORMAL COURSE ISSUER BID
NEUPATH HEALTH REPORTS THIRD QUARTER 2025 RESULTS
NEUPATH HEALTH TO REPORT Q3 RESULTS AND HOST INVESTOR WEBINAR
NEUPATH HEALTH TO PRESENT AT THE PLANET MICROCAP SHOWCASE: TORONTO IN PARTNERSHIP WITH THE MICROCAPCLUB ON WEDNESDAY, OCTOBER 22, 2025
NEUPATH HEALTH TO PRESENT AT THE ANNUAL SMALLCAP DISCOVERIES CONFERENCE IN VANCOUVER
NEUPATH HEALTH REPORTS SECOND QUARTER 2025 RESULTS
NEUPATH HEALTH TO REPORT Q2 RESULTS AND HOST INVESTOR WEBINAR
NEUPATH HEALTH ANNOUNCES VOTING RESULTS FROM THE ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
NEUPATH HEALTH REPORTS FIRST QUARTER 2025 RESULTS
NEUPATH HEALTH TO REPORT Q1 RESULTS AND HOST INVESTOR WEBINAR
NEUPATH HEALTH TO PRESENT AT THE 2025 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE
NEUPATH APPOINTS STEPHEN LEMIEUX AS PRESIDENT TO DRIVE NEXT PHASE OF STRATEGIC GROWTH
NEUPATH HEALTH REPORTS FOURTH QUARTER AND YEAR-END 2024 RESULTS
NEUPATH HEALTH SECURES NEW CREDIT FACILITIES TO DRIVE GROWTH AND TO REFINANCE EXISTING DEBT
NEUPATH HEALTH THE FIRST NORTH AMERICAN PROVIDER OF ARTHROSAMID®, A REVOLUTIONARY INJECTION FOR KNEE OSTEOARTHRITIS
NEUPATH HEALTH ANNOUNCES ISSUANCE OF STOCK OPTIONS AND RESTRICTED SHARE UNITS
NEUPATH HEALTH ANNOUNCES APPROVAL OF NORMAL COURSE ISSUER BID
NEUPATH HEALTH REPORTS THIRD QUARTER 2024 RESULTS
NEUPATH HEALTH TO BE FEATURED ON RADIUS RESEARCH’S PITCH, DEEP DIVE AND Q&A WEBINAR

Profile

NeuPath Health Inc operates an end-to-end, integrated network of healthcare businesses. It utilizes research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by acute and chronic musculoskeletal conditions, including chronic pain, spinal injuries, sports-related injuries, and concussions. It operates an interdisciplinary network of medical clinics in Ontario and Alberta, in addition to an independent medical assessment business with a national network of healthcare providers. Its medical clinics provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal or back injuries, sports-related injuries, and concussions.